Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+157.2%
5Y CAGR+74.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+157.2%/yr
vs -13.6%/yr prior
5Y CAGR
+74.7%/yr
Recent acceleration
Acceleration
+170.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
16.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.27M | +171.4% |
| 2024 | $3.05M | +64.9% |
| 2023 | $1.85M | +280.0% |
| 2022 | $486000.00 | +16100.0% |
| 2021 | $3000.00 | -99.4% |
| 2020 | $508000.00 | -39.2% |
| 2019 | $835000.00 | -4.4% |
| 2018 | $873000.00 | +127.9% |
| 2017 | $383000.00 | +303.2% |
| 2016 | $95000.00 | - |